Seeking Alpha · ACRS · October 27, 2026

Aclaris Therapeutics, Inc. (ACRS) Discusses ATI-052 Proof-of-Concept Results in Atopic Dermatitis and Asthma Transcript

Get the app for more

Explore stock news, insights and company research.